Analyst Ratings for Guardant Health
Portfolio Pulse from Benzinga Insights
In the last quarter, Guardant Health (NASDAQ:GH) received 1 bullish, 3 somewhat bullish, and 2 indifferent analyst ratings. The average 12-month price target for the company is $48.17, down 22.06% from the previous average of $61.80.
May 26, 2023 | 2:04 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Guardant Health received mixed analyst ratings in the last quarter, with an average 12-month price target of $48.17, down 22.06% from the previous average.
The article provides an overview of analyst ratings for Guardant Health in the last quarter. The mixed ratings and the decrease in the average 12-month price target suggest uncertainty in the stock's short-term performance. As a result, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100